Early research (Phase 1)Study completedNCT00002754
What this trial is testing
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors
Who this might be right for
Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
Duke University 6